| 000 | 03805cam a2200649 i 4500 | ||
|---|---|---|---|
| 001 | ocn909367934 | ||
| 003 | OCoLC | ||
| 005 | 20221128212907.0 | ||
| 006 | m d | ||
| 007 | cr ||||||||||| | ||
| 008 | 150116s2015 nyu ob 001 0 eng | ||
| 010 | _a 2019714032 | ||
| 040 |
_aDLC _beng _erda _cDLC _dN$T _dE7B _dEBLCP _dYDXCP _dAU@ _dSTF _dSCB |
||
| 019 | _a911246947 | ||
| 020 |
_a9781634821148 _qebook |
||
| 020 |
_a1634821149 _qebook |
||
| 020 |
_z1634821130 _qhbk. |
||
| 020 |
_z9781634821131 _qhbk. |
||
| 035 |
_a993181 _b(N$T) |
||
| 035 |
_a(OCoLC)909367934 _z(OCoLC)911246947 |
||
| 042 | _apcc | ||
| 072 | 7 |
_aHEA _x039000 _2bisacsh |
|
| 072 | 7 |
_aMED _x014000 _2bisacsh |
|
| 072 | 7 |
_aMED _x022000 _2bisacsh |
|
| 072 | 7 |
_aMED _x112000 _2bisacsh |
|
| 072 | 7 |
_aMED _x045000 _2bisacsh |
|
| 049 | _aMAIN | ||
| 245 | 0 | 0 |
_aHead and neck cancer : _bepidemiology, management and treatment outcomes _c _h[E-Book] |
| 264 | 1 |
_aNew York : _bNova Biomedical, _c[2015] |
|
| 300 | _a1 online resource. | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 490 | 1 | _aCancer etiology, diagnosis and treatments | |
| 504 | _aIncludes bibliographical references and index. | ||
| 588 | _aDescription based on print version record and CIP data provided by publisher. | ||
| 505 | 0 | _aChapter 1: Management of Mucositis in Head and Neck Cancer Patients; Abstract; Introduction; Clinical Course and Impact of OM; Assessment of Mucositis; Mucositis Prevention; Mucositis-Associated Pain; Opioid Use for Management of Mucositis-Associated Pain; Adjuvant Analgesic Therapies; Nutrition, Hydration and Electrolyte Support during Treatment; Conclusion and Future Directions | |
| 505 | 8 | _a2.2. Downstream Signaling Pathways of HER22.3. Gene Amplification, Protein Overexpression and Mutation of HER2; 3. The Significance of HER2 in; Head and Neck Cancer Treatment; 4. Specific Drugs Targeting HER2; 4.1. Monoclonal Antibodies; 4.2. Tyrosine Kinase Inhibitors; 4.2.1. Lapatinib; 4.2.2. Afatinib; 4.2.3. Dacomitinib; 5. Clinical Trials on HER2 in Head and Neck Cancer; Conclusion; References; Chapter 4: Current Trends and Management in Head and Neck Cancers; Abstract; 1. Head and Neck Squamous Cell Carcinoma; 3. Pathogenesis of Head and Neck Cancers; (i) p53 Pathway | |
| 520 | _aOver 50,000 new cases of head and neck cancer are diagnosed each year in the United States. The majority of these are squamous cell carcinoma (HNSCC), associated with human papillomavirus infection and carcinogenic behaviors such as tobacco use and alcohol consumption. Although these are more common, there are several other causes that this book addresses. This book examines the epidemiology of head and neck cancer. It discusses the management of head neck cancer as well as treatment outcomes. | ||
| 590 | _aMaster record variable field(s) change: 050, 082 | ||
| 650 | 0 |
_aHead _xCancer _xEpidemiology. |
|
| 650 | 0 |
_aHead _xCancer _xTreatment. |
|
| 650 | 0 |
_aNeck _xCancer _xEpidemiology. |
|
| 650 | 0 |
_aNeck _xCancer _xTreatment. |
|
| 650 | 2 |
_aHead and Neck Neoplasms _xetiology. |
|
| 650 | 2 |
_aHead and Neck Neoplasms _xdiagnosis. |
|
| 650 | 2 |
_aHead and Neck Neoplasms _xtherapy. |
|
| 700 | 1 |
_aHall, Madison R., _eeditor. |
|
| 830 | 0 | _aCancer etiology, diagnosis, and treatments. | |
| 856 | 4 | 0 |
_uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=993181 _yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
| 938 |
_aYBP Library Services _bYANK _n12257656 |
||
| 938 |
_aProQuest Ebook Central _bEBLB _nEBL2070564 |
||
| 938 |
_aebrary _bEBRY _nebr11055575 |
||
| 938 |
_aEBSCOhost _bEBSC _n993181 |
||
| 942 | _n0 | ||
| 994 |
_a92 _bN$T |
||
| 999 |
_c92185 _d92185 |
||